性福网站 I 男的操女的网站 I 香蕉网伊 I 亚洲国产精品一区 I 久草视频播放 I 亚洲字幕成人中文在线观看 I 国产精品亚洲一区二区三区在线观看 I 亚洲制服另类 I 国内精品久久久久伊人aⅴ I 宅男极品番号社 I 亚洲天堂网址 I 日本少妇xxxx I 青娱乐在线视频免费观看 I 亚洲精品综合在线观看 I 日韩电影网址 I 免播放器av I 国产精品一区无码 I 亚洲电影中文字幕 I 综合激情小说 I 一级欧美 I 黄在线网站 I 996久久国产精品线观看 I 97在线中文字幕 I 久久99精品国产麻豆蜜芽 I 岛国 中文字幕 I 日本成人h动漫在线 I 99久久婷婷国产综合精品电影√ I 电影在线一区二区 I 三级黄色,未满18 I 男女做爰猛烈啪啪吃奶图片 I 水野优香av在线区二区 I 日本高清在线www3344 I 天天做天天爱夜夜夜爽毛片 I 国产精品久久久. I 亚洲国产女人aaa毛片在线动漫 I 乱码1区2区3区4区 I 天堂av男人 I 国产精品26p I 亚洲欧美国产中文

一.產品名稱：

通用名稱：大/小鼠成纖維細胞生長因子23 ELISA試劑盒

英文名稱：Mouse/Rat FGF-23 ELISA Kit

二.Mouse FGF-23 ELISA介紹：

Mouse/Rat FGF-23 ELISA Kit is intended for research use only in the quantitative determination of Mouse FGF-23 levels in serum, plasma or cell culture media. This assay is also useful in the determination of Rat FGF-23 levels.
 

Fibroblast growth factor 23 (FGF-23) is a recently discovered, novel member of a large family of related proteins. Its gene encodes a 251 amino acid protein. The amino-terminal portion of FGF-23 (aa 1-24) is hydrophobic and is likely to serve as a signal peptide allowing its secretion into the blood circulation. Its carboxyl-terminal portion (aa 180-251) shares only limited amino acid homology with other members of the FGF family of proteins.

Renal phosphate wasting disorders leading to hypophosphatemia are among the causes of defective mineralization of bone and growth plate development. Autosomal dominant hypophosphatemic rickets (ADHR), a rare genetic disorder, results from one of several different FGF-23 mutations that make the protein resistant to proteolytic cleavage. Furthermore, tumors that cause oncogenic osteomalacia (OOM) have been shown to overexpress FGF-23 mRNA making it likely that elevated concentrations of FGF-23 in the blood are the cause of renal phosphate wasting. Consistent with this conclusion, the administration of recombinant FGF-23 to rodents was shown to increase urinary excretion of phosphate thus leading to hypophosphatemia and osteomalacia/rickets. Recent studies with chronic kidney disease (CKD) patients have shown FGF-23 to be an early predictor of abnormal renal tubular function, bone mineralization, disease progression and over-all mortality risk.

Taken together, all currently available data suggest that the measurement of FGF-23 levels may provide an important diagnostic tool for the evaluation of hypophosphatemic and hyperphosphatemic disorders.
 

如需了解更多產品，請北京科瑞美公司。